Mateo J - Search Results

1

Presentation of an acquired factor VIII inhibitor with a muscular haematoma mimicking a deep venous thrombosis in a patient with breast cancer.

López R, Mateo J, Cruz J, López A, Urrutia T, Fontcuberta J. López R, et al. Among authors: mateo j. Blood Coagul Fibrinolysis. 1995 Oct;6(7):680-2. doi: 10.1097/00001721-199510000-00010. Blood Coagul Fibrinolysis. 1995. PMID: 8562841

2

The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism.

Tirado I, Mateo J, Soria JM, Oliver A, Martínez-Sánchez E, Vallvé C, Borrell M, Urrutia T, Fontcuberta J. Tirado I, et al. Among authors: mateo j. Thromb Haemost. 2005 Mar;93(3):468-74. doi: 10.1160/TH04-04-0251. Thromb Haemost. 2005. PMID: 15735796

3

Acquired factor VIII inhibitor preceding chronic lymphocytic leukemia.

Mateo J, Martino R, Borrell M, Garí M, Casas F, Fontcuberta J. Mateo J, et al. Ann Hematol. 1993 Dec;67(6):309-11. doi: 10.1007/BF01696353. Ann Hematol. 1993. PMID: 8280815

4

Increased risk of venous thrombosis in carriers of natural anticoagulant deficiencies. Results of the family studies of the Spanish Multicenter Study on Thrombophilia (EMET study).

Mateo J, Oliver A, Borrell M, Sala N, Fontcuberta J. Mateo J, et al. Blood Coagul Fibrinolysis. 1998 Jan;9(1):71-8. doi: 10.1097/00001721-199801000-00009. Blood Coagul Fibrinolysis. 1998. PMID: 9607121

5

A new locus on chromosome 18 that influences normal variation in activated protein C resistance phenotype and factor VIII activity and its relation to thrombosis susceptibility.

Soria JM, Almasy L, Souto JC, Buil A, Martinez-Sanchez E, Mateo J, Borrell M, Stone WH, Lathrop M, Fontcuberta J, Blangero J. Soria JM, et al. Among authors: mateo j. Blood. 2003 Jan 1;101(1):163-7. doi: 10.1182/blood-2002-06-1792. Epub 2002 Aug 15. Blood. 2003. PMID: 12393556 Free article.

6

Rapid identification of female haemophilia A carriers with deletions in the factor VIII gene by quantitative real-time PCR analysis.

Tizzano EF, Barceló MJ, Baena M, Cornet M, Venceslá A, Mateo J, Fontcuberta J, Baiget M. Tizzano EF, et al. Among authors: mateo j. Thromb Haemost. 2005 Sep;94(3):661-4. doi: 10.1160/TH05-03-0144. Thromb Haemost. 2005. PMID: 16268486

7

Successful suppression using Rituximab of a factor VIII inhibitor in a boy with severe congenital haemophilia: an example of a significant decrease of treatment costs.

Mateo J, Badell I, Forner R, Borrell M, Tizzano E, Fontcuberta J. Mateo J, et al. Thromb Haemost. 2006 Feb;95(2):386-7. Thromb Haemost. 2006. PMID: 16493502 No abstract available.

8

Platelet hyperaggregability and venous thrombosis risk: results from the RETROVE project.

Llobet D, Vallvé C, Tirado I, Vilalta N, Carrasco M, Oliver A, Mateo J, Fontcuberta J, Souto JC. Llobet D, et al. Among authors: mateo j. Blood Coagul Fibrinolysis. 2021 Mar 1;32(2):122-131. doi: 10.1097/MBC.0000000000001006. Blood Coagul Fibrinolysis. 2021. PMID: 33337623

9

Low levels of tissue factor pathway inhibitor (TFPI) in two out of three members of a family with thrombophilia.

Llobet D, Falkon L, Mateo J, Vallvé C, Martínez E, Fontcuberta J, Borrell M. Llobet D, et al. Among authors: mateo j. Thromb Res. 1995 Dec 1;80(5):413-8. doi: 10.1016/0049-3848(95)00193-u. Thromb Res. 1995. PMID: 8588202

10

The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population.

Souto JC, Coll I, Llobet D, del Río E, Oliver A, Mateo J, Borrell M, Fontcuberta J. Souto JC, et al. Among authors: mateo j. Thromb Haemost. 1998 Sep;80(3):366-9. Thromb Haemost. 1998. PMID: 9759610

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

648 results

Search Page

Filters